Cargando…
PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ireland Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629147/ http://dx.doi.org/10.1016/S0167-8140(21)07914-7 |
_version_ | 1784607145613852672 |
---|---|
author | Orazem, M. Zumer, B. Segedin, B. Marinko, T. |
author_facet | Orazem, M. Zumer, B. Segedin, B. Marinko, T. |
author_sort | Orazem, M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8629147 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ireland Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86291472021-11-30 PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice? Orazem, M. Zumer, B. Segedin, B. Marinko, T. Radiother Oncol Digital Poster: Health services research/health economics Elsevier Ireland Ltd. 2021-08 2021-09-28 /pmc/articles/PMC8629147/ http://dx.doi.org/10.1016/S0167-8140(21)07914-7 Text en Copyright © 2021 Elsevier Ireland Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Digital Poster: Health services research/health economics Orazem, M. Zumer, B. Segedin, B. Marinko, T. PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice? |
title | PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice? |
title_full | PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice? |
title_fullStr | PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice? |
title_full_unstemmed | PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice? |
title_short | PO-1463 Is irradiation of SARS-CoV-2-positive cancer patients safe and feasible in clinical practice? |
title_sort | po-1463 is irradiation of sars-cov-2-positive cancer patients safe and feasible in clinical practice? |
topic | Digital Poster: Health services research/health economics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629147/ http://dx.doi.org/10.1016/S0167-8140(21)07914-7 |
work_keys_str_mv | AT orazemm po1463isirradiationofsarscov2positivecancerpatientssafeandfeasibleinclinicalpractice AT zumerb po1463isirradiationofsarscov2positivecancerpatientssafeandfeasibleinclinicalpractice AT segedinb po1463isirradiationofsarscov2positivecancerpatientssafeandfeasibleinclinicalpractice AT marinkot po1463isirradiationofsarscov2positivecancerpatientssafeandfeasibleinclinicalpractice |